Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ivabradine | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Ivabradine | hsa00310 | Lysine degradation | 1.53E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Ivabradine | hsa00500 | Starch and sucrose metabolism | 1.36E-03 | 3 | O43451, P35573, P06737 | MGAM, AGL, PYGL | More | | Ivabradine | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Ivabradine | hsa00562 | Inositol phosphate metabolism | 2.54E-03 | 4 | P27987, Q13572, Q96PE3, P42338 | ITPKB, ITPK1, INPP4A, PIK3CB | More | | Ivabradine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.46E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Ivabradine | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Ivabradine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Ivabradine | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Ivabradine | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Ivabradine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa03040 | Spliceosome | 3.31E-09 | 14 | Q14562, O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.745 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.734 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.76 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.859 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.787 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.784 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.714 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.747 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.712 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.822 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P35610 | SOAT1 | Sterol O-acyltransferase 1 | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | O15399 | GRIN2D | Glutamate receptor ionotropic, NMDA 2D | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.793 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Ivabradine | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04014 | Ras signaling pathway | 1.13E-04 | 10 | P42338, P20827, P49767, P08069, Q13009, Q7LDG7, P0DP23, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, IGF1R, TIAM1, RASGRP2, CALM1, GNG5, GNG10, PLCG1 | More | | Ivabradine | hsa04015 | Rap1 signaling pathway | 5.95E-03 | 9 | P20827, P49767, P08069, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, IGF1R, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Ivabradine | hsa04020 | Calcium signaling pathway | 5.15E-05 | 8 | P27987, P21796, Q16566, P30679, O15399, P0DP23, P23634, P49767 | ITPKB, VDAC1, CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Ivabradine | hsa04024 | cAMP signaling pathway | 1.49E-02 | 5 | P42338, P0DP23, P23634, Q16566, O15399 | PIK3CB, CALM1, ATP2B4, CAMK4, GRIN2D | More | | Ivabradine | hsa04062 | Chemokine signaling pathway | 9.23E-03 | 10 | P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, PIK3R5 | More | | Ivabradine | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04070 | Phosphatidylinositol signaling system | 1.49E-03 | 5 | P0DP23, P42338, Q96PE3, Q13572, P27987 | CALM1, PIK3CB, INPP4A, ITPK1, ITPKB | More | | Ivabradine | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | | Ivabradine | hsa04114 | Oocyte meiosis | 2.99E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Ivabradine | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04151 | PI3K-Akt signaling pathway | 1.89E-03 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Ivabradine | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Ivabradine | hsa04211 | Longevity regulating pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04213 | Longevity regulating pathway - multiple species | 1.66E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | | Ivabradine | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Ivabradine | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Ivabradine | hsa04371 | Apelin signaling pathway | 2.63E-04 | 9 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022, Q16566, P0DP23 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3, CAMK4, CALM1 | More | | Ivabradine | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Ivabradine | hsa04659 | Th17 cell differentiation | 1.70E-02 | 7 | P19174, P14784, P14778, P84022, Q13485, P08238, P07766 | PLCG1, IL2RB, IL1R1, SMAD3, SMAD4, HSP90AB1, CD3E | More | | Ivabradine | hsa04662 | B cell receptor signaling pathway | 9.03E-05 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Ivabradine | hsa04664 | Fc epsilon RI signaling pathway | 8.33E-05 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Ivabradine | hsa04666 | Fc gamma R-mediated phagocytosis | 4.10E-02 | 3 | P07948, P42338, P23528 | LYN, PIK3CB, CFL1 | More | | Ivabradine | hsa04713 | Circadian entrainment | 8.43E-03 | 4 | O15399, P0DP23, P63218, P50151 | GRIN2D, CALM1, GNG5, GNG10 | More | | Ivabradine | hsa04720 | Long-term potentiation | 1.63E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Ivabradine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Ivabradine | hsa04724 | Glutamatergic synapse | 3.15E-03 | 5 | O15399, P43003, P63218, P50151, P15104 | GRIN2D, SLC1A3, GNG5, GNG10, GLUL | More | | Ivabradine | hsa04725 | Cholinergic synapse | 5.94E-03 | 4 | P63218, P50151, Q16566, P42338 | GNG5, GNG10, CAMK4, PIK3CB | More | | Ivabradine | hsa04726 | Serotonergic synapse | 1.52E-02 | 4 | P63218, P50151, P33260, P09917 | GNG5, GNG10, CYP2C18, ALOX5 | More | | Ivabradine | hsa04728 | Dopaminergic synapse | 4.47E-02 | 4 | P63218, P50151, P0DP23, O00327 | GNG5, GNG10, CALM1, ARNTL | More | | Ivabradine | hsa04730 | Long-term depression | 1.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Ivabradine | hsa04913 | Ovarian steroidogenesis | 1.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Ivabradine | hsa04925 | Aldosterone synthesis and secretion | 3.14E-02 | 3 | P0DP23, Q16566, P23634 | CALM1, CAMK4, ATP2B4 | More | | Ivabradine | hsa04926 | Relaxin signaling pathway | 5.70E-03 | 5 | P42338, P63218, P50151, P49767, P30679 | PIK3CB, GNG5, GNG10, VEGFC, GNA15 | More | | Ivabradine | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Ivabradine | hsa04932 | Non-alcoholic fatty liver disease | 2.74E-02 | 3 | P01375, P49841, P48023 | TNF, GSK3B, FASLG | More | | Ivabradine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Ivabradine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Ivabradine | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Ivabradine | hsa05017 | Spinocerebellar ataxia | 5.94E-03 | 4 | Q8TB72, O15399, P42338, P21796 | PUM2, GRIN2D, PIK3CB, VDAC1 | More | | Ivabradine | hsa05034 | Alcoholism | 3.62E-02 | 5 | O15399, Q16566, P0DP23, P63218, P50151 | GRIN2D, CAMK4, CALM1, GNG5, GNG10 | More | | Ivabradine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | | Ivabradine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Ivabradine | hsa05163 | Human cytomegalovirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P0DP23, P30101 | PIK3CB, GNG5, GNG10, CALM1, PDIA3 | More | | Ivabradine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.19E-02 | 5 | P42338, P63218, P50151, P07948, P0DP23 | PIK3CB, GNG5, GNG10, LYN, CALM1 | More | | Ivabradine | hsa05170 | Human immunodeficiency virus 1 infection | 3.27E-02 | 6 | P42338, P63218, P50151, P0DP23, P30101, P23528 | PIK3CB, GNG5, GNG10, CALM1, PDIA3, CFL1 | More | | Ivabradine | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Ivabradine | hsa05202 | Transcriptional misregulation in cancer | 2.82E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05204 | Chemical carcinogenesis | 4.62E-02 | 2 | P78417, P33260 | GSTO1, CYP2C18 | More | | Ivabradine | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Ivabradine | hsa05214 | Glioma | 2.82E-03 | 4 | P08069, P0DP23, Q16566, P42338 | IGF1R, CALM1, CAMK4, PIK3CB | More | | Ivabradine | hsa05215 | Prostate cancer | 1.33E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Ivabradine | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | | Ivabradine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Ivabradine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | |